These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24397805)

  • 1. Effects of atorvastatin and insulin in vascular dysfunction associated with type 2 diabetes.
    Sena CM; Matafome P; Louro T; Nunes E; Seiça RM
    Physiol Res; 2014; 63(2):189-97. PubMed ID: 24397805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
    Matafome P; Nunes E; Louro T; Amaral C; Crisóstomo J; Rodrigues L; Moedas AR; Monteiro P; Cipriano A; Seiça R
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):241-51. PubMed ID: 18936912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
    Matafome P; Monteiro P; Nunes E; Louro T; Amaral C; Moedas AR; Gonçalves L; Providência L; Seiça R
    Pharmacol Res; 2008; 58(3-4):208-14. PubMed ID: 18692137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.
    Ceriello A; Assaloni R; Da Ros R; Maier A; Piconi L; Quagliaro L; Esposito K; Giugliano D
    Circulation; 2005 May; 111(19):2518-24. PubMed ID: 15867169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes.
    Akalin A; Temiz G; Akcar N; Sensoy B
    Endocr J; 2008 Oct; 55(5):861-6. PubMed ID: 18506090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function.
    Song X; Liu H; Wang X; Li Z; Huang C
    Lipids Health Dis; 2014 Dec; 13():186. PubMed ID: 25491404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative Randomized Study of the Effects of Long-Term Therapy With Rosuvastatin and Combination of Atorvastatin and Ezetimibe on Carbohydrate Metabolism and Adipokines Levels in Patients With Coronary Artery Disease and Diabetes Mellitus].
    Koshel'skaia OA; Vinnitskaia IV; Konko TIu; Kravchenko ES; Suslova TE; Karpov RS
    Kardiologiia; 2015; 55(3):67-74. PubMed ID: 26320293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes.
    van Etten RW; de Koning EJ; Honing ML; Stroes ES; Gaillard CA; Rabelink TJ
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):799-804. PubMed ID: 12006393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study.
    Tousoulis D; Koniari K; Antoniades C; Miliou A; Noutsou M; Nikolopoulou A; Papageorgiou N; Marinou K; Stefanadi E; Stefanadis C
    Clin Ther; 2010 Sep; 32(10):1720-8. PubMed ID: 21194594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
    Cheng ZJ; Vaskonen T; Tikkanen I; Nurminen K; Ruskoaho H; Vapaatalo H; Muller D; Park JK; Luft FC; Mervaala EM
    Hypertension; 2001 Feb; 37(2 Pt 2):433-9. PubMed ID: 11230314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.
    Tan KC; Chow WS; Tam SC; Ai VH; Lam CH; Lam KS
    J Clin Endocrinol Metab; 2002 Feb; 87(2):563-8. PubMed ID: 11836286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg.
    Brunetti ND; Maulucci G; Casavecchia GP; Distaso C; De Gennaro L; Pellegrino PL; Di Biase M
    J Interv Cardiol; 2007 Dec; 20(6):481-7. PubMed ID: 18042053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet.
    Sena CM; Louro T; Matafome P; Nunes E; Monteiro P; Seiça R
    Physiol Res; 2009; 58(2):203-209. PubMed ID: 18380531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.
    Fernandes R; Bento CF; Matafome P; Sena CM; Seiça RM; Pereira P
    Can J Physiol Pharmacol; 2014 Dec; 92(12):1037-43. PubMed ID: 25404034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress.
    Rösen P; Wiernsperger NF
    Diabetes Metab Res Rev; 2006; 22(4):323-30. PubMed ID: 16444763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
    Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T
    J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
    Huptas S; Geiss HC; Otto C; Parhofer KG
    Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin Improves Perivascular Adipose Tissue Profile and Vascular Dysfunction in Goto-Kakizaki Rats.
    Queiroz M; Leandro A; Azul L; Figueirinha A; Seiça R; Sena CM
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
    Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus.
    Tousoulis D; Koniari K; Antoniades C; Papageorgiou N; Miliou A; Noutsou M; Nikolopoulou A; Marinou K; Stefanadi E; Siasos G; Charakida M; Kamboli AM; Stefanadis C
    Int J Cardiol; 2011 May; 149(1):46-9. PubMed ID: 20034685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.